VESELÝ, Radek, Pavlina JELINKOVA, Dagmar HEGEROVA, Natalia CERNEI, Pavel KOPEL, Amitava MOULICK, Lukas RICHTERA, Zbynek HEGER, Vojtech ADAM and Ondrej ZITKA. Nanoparticles Suitable for BCAA Isolation Can Serve for Use in Magnetic Lipoplex-Based Delivery System for L, I, V, or R-rich Antimicrobial Peptides. Materials. Basel: MDPI AG, 2016, vol. 9, No 4, p. 1-15. ISSN 1996-1944. Available from: https://dx.doi.org/10.3390/ma9040260.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Nanoparticles Suitable for BCAA Isolation Can Serve for Use in Magnetic Lipoplex-Based Delivery System for L, I, V, or R-rich Antimicrobial Peptides
Authors VESELÝ, Radek (203 Czech Republic, guarantor, belonging to the institution), Pavlina JELINKOVA (203 Czech Republic), Dagmar HEGEROVA (203 Czech Republic), Natalia CERNEI (203 Czech Republic), Pavel KOPEL (203 Czech Republic), Amitava MOULICK (203 Czech Republic), Lukas RICHTERA (203 Czech Republic), Zbynek HEGER (203 Czech Republic), Vojtech ADAM (203 Czech Republic) and Ondrej ZITKA (203 Czech Republic).
Edition Materials, Basel, MDPI AG, 2016, 1996-1944.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30211 Orthopaedics
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.654
RIV identification code RIV/00216224:14110/16:00089659
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.3390/ma9040260
UT WoS 000375158900046
Keywords in English branched chain amino acids; encapsulation; Escherichia coli; nanomedicine; Staphylococcus aureus
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Ing. Mgr. Věra Pospíšilíková, učo 9005. Changed: 3/8/2016 12:54.
Abstract
This paper investigates the synthesis of paramagnetic nanoparticles, which are able to bind branched chain amino acids (BCAAs)-leucine, valine, and isoleucine and, thus, serve as a tool for their isolation. Further, by this, we present an approach for encapsulation of nanoparticles into a liposome cavity resulting in a delivery system. Analyses of valine and leucine in entire complex show that 31.3% and 32.6% recoveries are reached for those amino acids. Evaluation of results shows that the success rate of delivery in Escherichia coli (E. coli) is higher in the case of BCAAs on nanoparticles entrapped in liposomes (28.7% and 34.7% for valine and leucine, respectively) when compared to nanoparticles with no liposomal envelope (18.3% and 13.7% for valine and leucine, respectively). The nanoparticles with no liposomal envelope exhibit the negative zeta potential (-9.1 +/- 0.3 mV); however, their encapsulation results in a shift into positive values (range of 28.9 +/- 0.4 to 33.1 +/- 0.5 mV). Thus, electrostatic interactions with negatively-charged cell membranes (approx. -50 mV in the case of E. coli) leads to a better uptake of cargo. Our delivery system was finally tested with the leucine-rich antimicrobial peptide (FALALKALKKALKKLKKALKKAL) and it is shown that hemocompatibility (7.5%) and antimicrobial activity of the entire complex against E. coli, Staphylococcus aureus (S. aureus), and methicilin-resistant S. aureus (MRSA) is comparable or better than conventional penicillin antibiotics.
Links
ED1.1.00/02.0068, research and development projectName: CEITEC - central european institute of technology
PrintDisplayed: 22/7/2024 20:36